Crossmark

First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: A retrospective observational study (RETOSS-ENDO)

Crossref DOI link: https://doi.org/10.1016/j.endien.2021.07.002

Published Print: 2022-08

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pérez Pérez, Antonio

Ortega Martínez de Victoria, Emilio

Arrieta Blanco, Francisco

Caixàs Pedragós, Assumpta

Santos Mazo, Estefanía

Fernandez-Catalina, Pablo

Martínez-Hervas, Sergio

López-Medina, José Antonio

Suárez-Gutiérrez, Lorena

Urgeles Planelles, Juan Ramón

Gatell Menchén, Sònia

Tinahones Madueño, Francisco
License Information

Text and Data Mining valid from 2022-08-01
More Information

This article is maintained by: Elsevier

Article Title: First clinical and efficacy data on evolocumab in routine clinical practice in endocrinology and nutrition services in Spain: A retrospective observational study (RETOSS-ENDO)

Journal Title: Endocrinología, Diabetes y Nutrición (English ed.)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.endien.2021.07.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.endinu.2021.07.009

Content Type: article

Copyright: © 2022 Published by Elsevier España, S.L.U. on behalf of SEEN and SED.

Document is current

Any future updates will be listed below